These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2203313)

  • 21. Activity of meropenem, against gram-positive bacteria.
    Kayser FH; Morenzoni G; Strässle A; Hadorn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
    Williams RJ; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of CGP 31608, a new penem.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M; Sekine Y; Shimizu S; Takano H; Angehrn P; Then RL
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem.
    Ohba F; Nakamura-Kamijo M; Watanabe N; Katsu K
    Antimicrob Agents Chemother; 1997 Feb; 41(2):298-307. PubMed ID: 9021183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
    Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.
    Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.
    Tanaka M; Hohmura M; Nishi T; Sato K; Hayakawa I
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1260-8. PubMed ID: 9174181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel dithiocarbamate carbapenems with anti-MRSA activity.
    Ohtake N; Imamura H; Jona H; Kiyonaga H; Shimizu A; Moriya M; Sato H; Nakano M; Ushijima R; Nakagawa S
    Bioorg Med Chem; 1998 Jul; 6(7):1089-101. PubMed ID: 9730246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R; Cross C; Andrews JM
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinities of BO-2727 for bacterial penicillin-binding proteins and morphological change of gram-negative rods.
    Hashizume T; Nakamura K; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):139-42. PubMed ID: 9099223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
    Fung-Tomc JC; Gradelski E; Kolek B; Minassian B; Pucci M; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N; Katsu K; Moriyama M; Kitoh K
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem.
    Neu HC; Chin NX; Saha G; Labthavikul P
    Antimicrob Agents Chemother; 1986 Dec; 30(6):828-34. PubMed ID: 3545068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
    Limbert M; Isert D; Klesel N; Markus A; Seeger K; Seibert G; Schrinner E
    Antimicrob Agents Chemother; 1991 Jan; 35(1):14-9. PubMed ID: 2014969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antibacterial activity of FK041, a new orally active cephalosporin.
    Watanabe Y; Hatano K; Matsumoto Y; Tawara S; Yamamoto H; Kawabata K; Takasugi H; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1999 Jul; 52(7):649-59. PubMed ID: 10513845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R; Andrews JM; Cross C; Piddock LJ
    J Antimicrob Chemother; 1985 Apr; 15(4):449-56. PubMed ID: 3874198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.